nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—adrenal gland cancer	0.807	1	CbGaD
Clodronate—SLC25A5—Electron Transport Chain—SDHB—adrenal gland cancer	0.0104	0.0865	CbGpPWpGaD
Clodronate—SLC25A6—Electron Transport Chain—SDHB—adrenal gland cancer	0.00875	0.0725	CbGpPWpGaD
Clodronate—SLC25A5—adrenal cortex—adrenal gland cancer	0.00767	0.106	CbGeAlD
Clodronate—SLC25A6—gonad—adrenal gland cancer	0.00731	0.101	CbGeAlD
Clodronate—SLC25A4—Electron Transport Chain—SDHB—adrenal gland cancer	0.00683	0.0566	CbGpPWpGaD
Clodronate—SLC25A5—Electron Transport Chain—SDHD—adrenal gland cancer	0.00673	0.0557	CbGpPWpGaD
Clodronate—SLC25A6—adrenal gland—adrenal gland cancer	0.00637	0.088	CbGeAlD
Clodronate—SLC25A5—gonad—adrenal gland cancer	0.00635	0.0878	CbGeAlD
Clodronate—SLC25A5—cardiac atrium—adrenal gland cancer	0.00635	0.0877	CbGeAlD
Clodronate—SLC25A5—pituitary gland—adrenal gland cancer	0.0062	0.0857	CbGeAlD
Clodronate—SLC25A4—gonad—adrenal gland cancer	0.00596	0.0823	CbGeAlD
Clodronate—SLC25A4—cardiac atrium—adrenal gland cancer	0.00595	0.0822	CbGeAlD
Clodronate—SLC25A4—pituitary gland—adrenal gland cancer	0.00581	0.0803	CbGeAlD
Clodronate—SLC25A6—Electron Transport Chain—SDHD—adrenal gland cancer	0.00564	0.0467	CbGpPWpGaD
Clodronate—SLC25A5—adrenal gland—adrenal gland cancer	0.00554	0.0766	CbGeAlD
Clodronate—SLC25A4—adrenal gland—adrenal gland cancer	0.00519	0.0717	CbGeAlD
Clodronate—SLC25A5—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00462	0.0383	CbGpPWpGaD
Clodronate—SLC25A4—Electron Transport Chain—SDHD—adrenal gland cancer	0.0044	0.0365	CbGpPWpGaD
Clodronate—SLC25A6—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00387	0.0321	CbGpPWpGaD
Clodronate—SLC25A5—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00374	0.031	CbGpPWpGaD
Clodronate—SLC25A5—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00363	0.0301	CbGpPWpGaD
Clodronate—SLC25A6—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00314	0.026	CbGpPWpGaD
Clodronate—SLC25A6—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00304	0.0252	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00302	0.025	CbGpPWpGaD
Clodronate—SLC25A5—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00294	0.0244	CbGpPWpGaD
Clodronate—SLC25A6—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00247	0.0204	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00245	0.0203	CbGpPWpGaD
Clodronate—SLC25A4—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00237	0.0197	CbGpPWpGaD
Clodronate—SLC25A4—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00192	0.0159	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00172	0.0142	CbGpPWpGaD
Clodronate—PTGS2—adrenal cortex—adrenal gland cancer	0.00144	0.02	CbGeAlD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—PRKACA—adrenal gland cancer	0.0013	0.0108	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SH3KBP1—adrenal gland cancer	0.0012	0.00996	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—SDHB—adrenal gland cancer	0.00118	0.00981	CbGpPWpGaD
Clodronate—PTGS2—pituitary gland—adrenal gland cancer	0.00117	0.0161	CbGeAlD
Clodronate—SLC25A5—Disease—ZNRF3—adrenal gland cancer	0.00113	0.00937	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—REN—adrenal gland cancer	0.00111	0.00916	CbGpPWpGaD
Clodronate—PTGS2—adrenal gland—adrenal gland cancer	0.00104	0.0144	CbGeAlD
Clodronate—SLC25A6—Disease—SH3KBP1—adrenal gland cancer	0.00101	0.00835	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—SDHB—adrenal gland cancer	0.000992	0.00822	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ZNRF3—adrenal gland cancer	0.000947	0.00785	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—REN—adrenal gland cancer	0.000863	0.00715	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SH3KBP1—adrenal gland cancer	0.000787	0.00652	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SDHB—adrenal gland cancer	0.000775	0.00642	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—RRM1—adrenal gland cancer	0.000763	0.00632	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—SDHD—adrenal gland cancer	0.000763	0.00632	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ZNRF3—adrenal gland cancer	0.00074	0.00613	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SPRY2—adrenal gland cancer	0.000709	0.00587	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000669	0.00554	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MEN1—adrenal gland cancer	0.000649	0.00538	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—SDHD—adrenal gland cancer	0.000639	0.0053	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—RRM1—adrenal gland cancer	0.000639	0.0053	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SPRY2—adrenal gland cancer	0.000594	0.00492	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000571	0.00473	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MED12—adrenal gland cancer	0.000569	0.00471	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—IGF2—adrenal gland cancer	0.000552	0.00457	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MEN1—adrenal gland cancer	0.000544	0.00451	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000531	0.0044	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—RRM1—adrenal gland cancer	0.000499	0.00414	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SDHD—adrenal gland cancer	0.000499	0.00414	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PRKACA—adrenal gland cancer	0.000496	0.00411	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000477	0.00396	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MED12—adrenal gland cancer	0.000477	0.00395	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SPRY2—adrenal gland cancer	0.000464	0.00384	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—IGF2—adrenal gland cancer	0.000431	0.00357	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MEN1—adrenal gland cancer	0.000425	0.00352	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDC42—adrenal gland cancer	0.00042	0.00348	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PRKACA—adrenal gland cancer	0.000415	0.00344	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PRKACA—adrenal gland cancer	0.000415	0.00344	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MED12—adrenal gland cancer	0.000372	0.00308	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—POMC—adrenal gland cancer	0.000368	0.00305	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00036	0.00298	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDC42—adrenal gland cancer	0.000352	0.00292	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PRKACA—adrenal gland cancer	0.000348	0.00288	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TERT—adrenal gland cancer	0.000337	0.00279	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GNAS—adrenal gland cancer	0.000336	0.00279	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCB1—adrenal gland cancer	0.00033	0.00274	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000328	0.00272	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PRKACA—adrenal gland cancer	0.000324	0.00269	CbGpPWpGaD
Clodronate—SLC25A5—Disease—BAD—adrenal gland cancer	0.000293	0.00243	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000291	0.00241	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—POMC—adrenal gland cancer	0.000288	0.00238	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TERT—adrenal gland cancer	0.000283	0.00234	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GNAS—adrenal gland cancer	0.000282	0.00234	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000278	0.00231	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—adrenal gland cancer	0.000277	0.00229	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDC42—adrenal gland cancer	0.000275	0.00228	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PRKACA—adrenal gland cancer	0.000272	0.00225	CbGpPWpGaD
Clodronate—SLC25A5—Disease—BRAF—adrenal gland cancer	0.000267	0.00221	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000263	0.00218	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.000259	0.00215	CbGpPWpGaD
Clodronate—SLC25A6—Disease—BAD—adrenal gland cancer	0.000246	0.00204	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00023	0.0019	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—POMC—adrenal gland cancer	0.000227	0.00188	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000225	0.00186	CbGpPWpGaD
Clodronate—SLC25A6—Disease—BRAF—adrenal gland cancer	0.000224	0.00185	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TERT—adrenal gland cancer	0.000221	0.00183	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GNAS—adrenal gland cancer	0.00022	0.00182	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCB1—adrenal gland cancer	0.000216	0.00179	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—adrenal gland cancer	0.000216	0.00179	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000205	0.0017	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CTNNB1—adrenal gland cancer	0.000193	0.0016	CbGpPWpGaD
Clodronate—SLC25A4—Disease—BAD—adrenal gland cancer	0.000192	0.00159	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—POMC—adrenal gland cancer	0.00019	0.00157	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—adrenal gland cancer	0.000181	0.0015	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—adrenal gland cancer	0.000181	0.0015	CbGpPWpGaD
Clodronate—SLC25A4—Disease—BRAF—adrenal gland cancer	0.000175	0.00145	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000171	0.00142	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000165	0.00137	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CTNNB1—adrenal gland cancer	0.000162	0.00134	CbGpPWpGaD
Clodronate—PTGS2—Disease—SH3KBP1—adrenal gland cancer	0.000156	0.00129	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDHB—adrenal gland cancer	0.000153	0.00127	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—adrenal gland cancer	0.000153	0.00127	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—adrenal gland cancer	0.000151	0.00125	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—POMC—adrenal gland cancer	0.000148	0.00123	CbGpPWpGaD
Clodronate—PTGS2—Disease—ZNRF3—adrenal gland cancer	0.000146	0.00121	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—adrenal gland cancer	0.000141	0.00117	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000131	0.00108	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—adrenal gland cancer	0.000128	0.00106	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CTNNB1—adrenal gland cancer	0.000126	0.00105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000121	0.000999	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—adrenal gland cancer	0.000118	0.000979	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000112	0.000932	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	0.00011	0.000911	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—adrenal gland cancer	0.0001	0.000829	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—RRM1—adrenal gland cancer	9.87e-05	0.000818	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDHD—adrenal gland cancer	9.87e-05	0.000818	CbGpPWpGaD
Clodronate—PTGS2—Disease—SPRY2—adrenal gland cancer	9.17e-05	0.000759	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.91e-05	0.000738	CbGpPWpGaD
Clodronate—PTGS2—Disease—MEN1—adrenal gland cancer	8.4e-05	0.000696	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.48e-05	0.00062	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MED12—adrenal gland cancer	7.36e-05	0.00061	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.58e-05	0.000545	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKACA—adrenal gland cancer	6.41e-05	0.000531	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDC42—adrenal gland cancer	5.44e-05	0.000451	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PRKACA—adrenal gland cancer	5.37e-05	0.000445	CbGpPWpGaD
Clodronate—PTGS2—Disease—TERT—adrenal gland cancer	4.36e-05	0.000361	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNAS—adrenal gland cancer	4.35e-05	0.000361	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—adrenal gland cancer	4.27e-05	0.000354	CbGpPWpGaD
Clodronate—PTGS2—Disease—BAD—adrenal gland cancer	3.79e-05	0.000314	CbGpPWpGaD
Clodronate—PTGS2—Disease—BRAF—adrenal gland cancer	3.45e-05	0.000286	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—POMC—adrenal gland cancer	2.93e-05	0.000243	CbGpPWpGaD
Clodronate—PTGS2—Disease—CTNNB1—adrenal gland cancer	2.5e-05	0.000207	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—adrenal gland cancer	1.98e-05	0.000164	CbGpPWpGaD
